| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium tuberculosis | 48 | 2024 | 329 | 13.680 |
Why?
|
| Tuberculosis | 22 | 2024 | 543 | 6.050 |
Why?
|
| Bacterial Proteins | 24 | 2024 | 119 | 4.850 |
Why?
|
| Peptidoglycan | 11 | 2024 | 11 | 4.770 |
Why?
|
| Mycobacterium smegmatis | 16 | 2023 | 20 | 4.690 |
Why?
|
| Tuberculosis, Pulmonary | 13 | 2024 | 324 | 3.570 |
Why?
|
| Sputum | 11 | 2023 | 135 | 3.170 |
Why?
|
| Cell Wall | 7 | 2023 | 9 | 2.670 |
Why?
|
| Cytokines | 11 | 2024 | 107 | 2.240 |
Why?
|
| Antitubercular Agents | 13 | 2022 | 322 | 2.140 |
Why?
|
| Coinfection | 5 | 2022 | 276 | 1.960 |
Why?
|
| Bacillus | 2 | 2023 | 7 | 1.700 |
Why?
|
| Humans | 48 | 2024 | 14537 | 1.690 |
Why?
|
| Bacteriological Techniques | 2 | 2021 | 54 | 1.440 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 3 | 2022 | 226 | 1.360 |
Why?
|
| Bacteria | 2 | 2020 | 47 | 1.270 |
Why?
|
| Animals | 19 | 2024 | 1081 | 1.170 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 3 | 2020 | 5 | 1.070 |
Why?
|
| Genetic Variation | 2 | 2020 | 175 | 1.060 |
Why?
|
| Gene Deletion | 10 | 2021 | 19 | 0.990 |
Why?
|
| Genes, Bacterial | 4 | 2019 | 23 | 0.960 |
Why?
|
| BCG Vaccine | 1 | 2024 | 20 | 0.910 |
Why?
|
| Glutamic Acid | 1 | 2023 | 2 | 0.880 |
Why?
|
| Amides | 1 | 2023 | 8 | 0.870 |
Why?
|
| Nitrate Reductase | 2 | 2021 | 3 | 0.850 |
Why?
|
| AIDS-Related Opportunistic Infections | 3 | 2021 | 195 | 0.830 |
Why?
|
| Penicillin-Binding Proteins | 2 | 2020 | 7 | 0.780 |
Why?
|
| Aminoacyltransferases | 2 | 2019 | 3 | 0.770 |
Why?
|
| Endopeptidases | 1 | 2021 | 3 | 0.770 |
Why?
|
| Vaccines | 1 | 2023 | 86 | 0.770 |
Why?
|
| beta-Lactamases | 2 | 2020 | 23 | 0.770 |
Why?
|
| Nucleic Acids | 1 | 2021 | 7 | 0.750 |
Why?
|
| Mice | 13 | 2024 | 135 | 0.740 |
Why?
|
| Virulence Factors | 2 | 2013 | 18 | 0.710 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 44 | 0.700 |
Why?
|
| Sulfurtransferases | 3 | 2015 | 3 | 0.700 |
Why?
|
| Latent Tuberculosis | 2 | 2019 | 45 | 0.680 |
Why?
|
| Reference Standards | 2 | 2017 | 29 | 0.670 |
Why?
|
| Carboxypeptidases | 1 | 2019 | 1 | 0.650 |
Why?
|
| Endemic Diseases | 1 | 2018 | 15 | 0.630 |
Why?
|
| Mutation | 7 | 2023 | 306 | 0.620 |
Why?
|
| Biofilms | 1 | 2018 | 15 | 0.610 |
Why?
|
| beta-Lactam Resistance | 1 | 2018 | 5 | 0.610 |
Why?
|
| beta-Lactams | 1 | 2018 | 7 | 0.610 |
Why?
|
| HIV Infections | 3 | 2023 | 5097 | 0.600 |
Why?
|
| Microbial Sensitivity Tests | 7 | 2022 | 198 | 0.590 |
Why?
|
| Pathology, Molecular | 1 | 2017 | 5 | 0.580 |
Why?
|
| Mycobacterium | 3 | 2018 | 16 | 0.570 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 12 | 0.570 |
Why?
|
| Cell Division | 1 | 2017 | 12 | 0.570 |
Why?
|
| Staphylococcal Infections | 1 | 2017 | 31 | 0.560 |
Why?
|
| Pandemics | 3 | 2023 | 296 | 0.540 |
Why?
|
| Energy Metabolism | 2 | 2014 | 13 | 0.510 |
Why?
|
| Coenzymes | 2 | 2013 | 2 | 0.510 |
Why?
|
| Metalloproteins | 2 | 2013 | 2 | 0.510 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 10 | 0.490 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 12 | 0.480 |
Why?
|
| Guanine Nucleotides | 1 | 2014 | 1 | 0.480 |
Why?
|
| Pterins | 1 | 2014 | 1 | 0.480 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 266 | 0.480 |
Why?
|
| Drug Discovery | 1 | 2014 | 23 | 0.470 |
Why?
|
| Gene Expression Regulation, Bacterial | 7 | 2014 | 9 | 0.470 |
Why?
|
| Lung | 5 | 2019 | 70 | 0.470 |
Why?
|
| Firmicutes | 2 | 2023 | 7 | 0.430 |
Why?
|
| Biosynthetic Pathways | 1 | 2013 | 3 | 0.420 |
Why?
|
| Adult | 7 | 2024 | 5913 | 0.400 |
Why?
|
| Female | 12 | 2024 | 9103 | 0.400 |
Why?
|
| Bacterial Load | 2 | 2023 | 32 | 0.390 |
Why?
|
| HIV | 3 | 2021 | 380 | 0.390 |
Why?
|
| Macrophages | 3 | 2024 | 15 | 0.390 |
Why?
|
| Rifampin | 4 | 2022 | 197 | 0.380 |
Why?
|
| Signal Transduction | 2 | 2013 | 33 | 0.350 |
Why?
|
| Anti-Bacterial Agents | 4 | 2018 | 293 | 0.330 |
Why?
|
| Prevalence | 3 | 2018 | 1192 | 0.330 |
Why?
|
| Cells | 1 | 2009 | 2 | 0.320 |
Why?
|
| Tuberculosis Vaccines | 2 | 2011 | 8 | 0.320 |
Why?
|
| Seasons | 1 | 2009 | 154 | 0.310 |
Why?
|
| Schools | 1 | 2009 | 73 | 0.300 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 280 | 0.300 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 385 | 0.290 |
Why?
|
| South Africa | 8 | 2023 | 7596 | 0.290 |
Why?
|
| Guinea Pigs | 2 | 2018 | 11 | 0.280 |
Why?
|
| Computational Biology | 2 | 2019 | 44 | 0.270 |
Why?
|
| Africa | 2 | 2023 | 376 | 0.270 |
Why?
|
| Electron Transport Chain Complex Proteins | 2 | 2005 | 2 | 0.260 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 45 | 0.250 |
Why?
|
| Vancomycin | 2 | 2018 | 6 | 0.240 |
Why?
|
| DNA Repair | 2 | 2015 | 11 | 0.240 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2024 | 1 | 0.230 |
Why?
|
| Culture Media | 4 | 2022 | 15 | 0.230 |
Why?
|
| Amino Acid Motifs | 3 | 2021 | 10 | 0.230 |
Why?
|
| Biomimetics | 1 | 2023 | 3 | 0.220 |
Why?
|
| Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor | 1 | 2023 | 1 | 0.220 |
Why?
|
| Mucous Membrane | 1 | 2023 | 12 | 0.220 |
Why?
|
| Mutagenesis, Insertional | 3 | 2010 | 8 | 0.220 |
Why?
|
| Transcription, Genetic | 3 | 2020 | 14 | 0.220 |
Why?
|
| Male | 6 | 2024 | 6754 | 0.220 |
Why?
|
| Protein Structure, Secondary | 2 | 2021 | 12 | 0.220 |
Why?
|
| Microbial Viability | 2 | 2017 | 11 | 0.220 |
Why?
|
| Tuberculosis, Spinal | 1 | 2022 | 2 | 0.210 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2023 | 56 | 0.210 |
Why?
|
| Agar | 1 | 2022 | 3 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2023 | 198 | 0.200 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 1422 | 0.200 |
Why?
|
| Disease Management | 1 | 2022 | 74 | 0.200 |
Why?
|
| Genotype | 3 | 2020 | 442 | 0.200 |
Why?
|
| Amidohydrolases | 1 | 2021 | 1 | 0.200 |
Why?
|
| Cytochromes | 1 | 2001 | 1 | 0.200 |
Why?
|
| Escherichia coli Proteins | 1 | 2001 | 2 | 0.200 |
Why?
|
| Oxidoreductases | 1 | 2001 | 7 | 0.190 |
Why?
|
| Species Specificity | 2 | 2020 | 49 | 0.190 |
Why?
|
| Tongue | 1 | 2021 | 5 | 0.190 |
Why?
|
| Culture Media, Conditioned | 1 | 2021 | 4 | 0.190 |
Why?
|
| Child, Hospitalized | 1 | 2021 | 26 | 0.190 |
Why?
|
| Epidemics | 2 | 2019 | 65 | 0.190 |
Why?
|
| Nitrates | 1 | 2021 | 2 | 0.180 |
Why?
|
| Microscopy, Fluorescence | 2 | 2019 | 4 | 0.180 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 303 | 0.180 |
Why?
|
| Phylogeny | 1 | 2021 | 231 | 0.180 |
Why?
|
| Public Health Administration | 1 | 2020 | 14 | 0.180 |
Why?
|
| Mass Vaccination | 1 | 2020 | 11 | 0.180 |
Why?
|
| Health Equity | 1 | 2020 | 12 | 0.180 |
Why?
|
| Cytoskeleton | 1 | 2020 | 1 | 0.180 |
Why?
|
| Phosphorylation | 1 | 2020 | 6 | 0.180 |
Why?
|
| Protein Interaction Maps | 1 | 2020 | 3 | 0.170 |
Why?
|
| Carbon | 2 | 2013 | 5 | 0.170 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 101 | 0.170 |
Why?
|
| Fluoresceins | 1 | 2019 | 2 | 0.170 |
Why?
|
| Fluorescent Dyes | 1 | 2019 | 13 | 0.170 |
Why?
|
| Oligopeptides | 1 | 2019 | 16 | 0.170 |
Why?
|
| Hypoxia | 1 | 2019 | 12 | 0.170 |
Why?
|
| Resuscitation | 1 | 2019 | 18 | 0.170 |
Why?
|
| Genome, Bacterial | 3 | 2015 | 32 | 0.160 |
Why?
|
| Mutagenesis | 3 | 2015 | 6 | 0.160 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 21 | 0.160 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 46 | 0.160 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2017 | 135 | 0.160 |
Why?
|
| Operon | 1 | 2019 | 1 | 0.160 |
Why?
|
| Multigene Family | 1 | 2019 | 6 | 0.160 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2019 | 16 | 0.160 |
Why?
|
| Microbiota | 1 | 2019 | 30 | 0.160 |
Why?
|
| Disease Eradication | 1 | 2019 | 11 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 36 | 0.160 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 252 | 0.160 |
Why?
|
| Transcriptome | 1 | 2018 | 14 | 0.160 |
Why?
|
| HIV Seropositivity | 1 | 2021 | 265 | 0.160 |
Why?
|
| Muramic Acids | 1 | 2018 | 1 | 0.160 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2018 | 1 | 0.160 |
Why?
|
| Viral Load | 1 | 2022 | 819 | 0.150 |
Why?
|
| Escherichia coli | 2 | 2016 | 30 | 0.150 |
Why?
|
| RNA, Messenger | 1 | 2018 | 32 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2019 | 49 | 0.150 |
Why?
|
| Molecular Weight | 1 | 2018 | 13 | 0.150 |
Why?
|
| Conserved Sequence | 3 | 2014 | 10 | 0.150 |
Why?
|
| Recombination, Genetic | 1 | 2017 | 27 | 0.140 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 53 | 0.140 |
Why?
|
| Africa South of the Sahara | 1 | 2018 | 353 | 0.140 |
Why?
|
| Microscopy, Electron | 1 | 2017 | 5 | 0.140 |
Why?
|
| Permeability | 1 | 2017 | 17 | 0.140 |
Why?
|
| Biomarkers | 1 | 2018 | 327 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 1 | 2017 | 5 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 7 | 0.140 |
Why?
|
| Bacterial Typing Techniques | 1 | 2017 | 11 | 0.140 |
Why?
|
| Pleural Cavity | 1 | 2017 | 7 | 0.140 |
Why?
|
| Recurrence | 1 | 2017 | 29 | 0.140 |
Why?
|
| Middle Aged | 2 | 2024 | 3601 | 0.140 |
Why?
|
| Radiography | 1 | 2017 | 80 | 0.140 |
Why?
|
| Monocytes | 2 | 2014 | 27 | 0.140 |
Why?
|
| Nitrogenous Group Transferases | 1 | 2016 | 1 | 0.140 |
Why?
|
| Transfer RNA Aminoacylation | 1 | 2016 | 1 | 0.140 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 8 | 0.130 |
Why?
|
| Organometallic Compounds | 1 | 2016 | 3 | 0.130 |
Why?
|
| Child, Preschool | 1 | 2021 | 1748 | 0.130 |
Why?
|
| Adenosine Triphosphate | 2 | 2014 | 8 | 0.130 |
Why?
|
| Comorbidity | 1 | 2016 | 188 | 0.130 |
Why?
|
| Pteridines | 2 | 2013 | 3 | 0.130 |
Why?
|
| Oxygen Consumption | 3 | 2005 | 15 | 0.130 |
Why?
|
| DNA-Formamidopyrimidine Glycosylase | 1 | 2015 | 2 | 0.120 |
Why?
|
| DNA Glycosylases | 1 | 2015 | 4 | 0.120 |
Why?
|
| Proteolysis | 1 | 2015 | 2 | 0.120 |
Why?
|
| Mycobacterium bovis | 1 | 2014 | 4 | 0.120 |
Why?
|
| Child | 1 | 2021 | 2242 | 0.120 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2018 | 132 | 0.120 |
Why?
|
| Gene Expression | 1 | 2015 | 43 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 10 | 0.120 |
Why?
|
| Environmental Microbiology | 1 | 2014 | 1 | 0.110 |
Why?
|
| Mycobacterium Infections | 1 | 2014 | 2 | 0.110 |
Why?
|
| Proton-Motive Force | 1 | 2014 | 1 | 0.110 |
Why?
|
| Biological Transport | 1 | 2014 | 11 | 0.110 |
Why?
|
| Anti-Retroviral Agents | 1 | 2018 | 551 | 0.110 |
Why?
|
| Endodeoxyribonucleases | 1 | 2013 | 1 | 0.110 |
Why?
|
| Retrospective Studies | 1 | 2017 | 799 | 0.110 |
Why?
|
| Cytochromes c | 1 | 2013 | 2 | 0.110 |
Why?
|
| Desiccation | 1 | 2013 | 15 | 0.110 |
Why?
|
| Virulence | 3 | 2008 | 25 | 0.110 |
Why?
|
| Protein Binding | 2 | 2010 | 62 | 0.110 |
Why?
|
| Nitrogen | 1 | 2013 | 1 | 0.110 |
Why?
|
| Sulfur | 1 | 2013 | 2 | 0.110 |
Why?
|
| Enzymes | 1 | 2013 | 2 | 0.110 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 24 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2010 | 79 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 77 | 0.100 |
Why?
|
| Specimen Handling | 1 | 2013 | 105 | 0.100 |
Why?
|
| Genetic Complementation Test | 2 | 2008 | 2 | 0.090 |
Why?
|
| Anti-HIV Agents | 2 | 2021 | 1324 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 43 | 0.090 |
Why?
|
| Electron Transport | 3 | 2013 | 3 | 0.090 |
Why?
|
| Oxygen | 3 | 2013 | 25 | 0.090 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2010 | 8 | 0.090 |
Why?
|
| Erythromycin | 1 | 2010 | 12 | 0.090 |
Why?
|
| Acrolein | 1 | 2010 | 1 | 0.090 |
Why?
|
| Benzopyrenes | 1 | 2010 | 1 | 0.090 |
Why?
|
| Nitrofurazone | 1 | 2010 | 1 | 0.090 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2010 | 1 | 0.090 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2010 | 1 | 0.090 |
Why?
|
| Quinolones | 1 | 2010 | 7 | 0.090 |
Why?
|
| Ribonucleotide Reductases | 1 | 2008 | 2 | 0.080 |
Why?
|
| Glycolipids | 1 | 2008 | 1 | 0.080 |
Why?
|
| Propionates | 1 | 2008 | 1 | 0.080 |
Why?
|
| Vitamin B 12 | 1 | 2008 | 4 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2008 | 12 | 0.080 |
Why?
|
| Antigens, Bacterial | 1 | 2008 | 32 | 0.080 |
Why?
|
| Detergents | 1 | 2008 | 2 | 0.070 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 14 | 0.070 |
Why?
|
| Peritoneum | 1 | 2007 | 5 | 0.070 |
Why?
|
| Disease Progression | 2 | 2019 | 154 | 0.070 |
Why?
|
| Electron Transport Complex III | 1 | 2005 | 1 | 0.060 |
Why?
|
| Brazil | 1 | 2024 | 47 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2004 | 9 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 28 | 0.060 |
Why?
|
| Axenic Culture | 1 | 2022 | 1 | 0.050 |
Why?
|
| Biopsy | 1 | 2022 | 38 | 0.050 |
Why?
|
| Disaccharides | 1 | 2022 | 1 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 5 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 7 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2010 | 263 | 0.050 |
Why?
|
| Atmospheric Pressure | 1 | 2001 | 1 | 0.050 |
Why?
|
| Cyanides | 1 | 2001 | 1 | 0.050 |
Why?
|
| Cytochrome b Group | 1 | 2001 | 1 | 0.050 |
Why?
|
| Spectrophotometry | 1 | 2001 | 1 | 0.050 |
Why?
|
| Immunity | 1 | 2021 | 10 | 0.050 |
Why?
|
| Alanine | 1 | 2021 | 31 | 0.050 |
Why?
|
| Models, Biological | 1 | 2001 | 77 | 0.050 |
Why?
|
| Microscopy | 1 | 2021 | 21 | 0.050 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2021 | 35 | 0.050 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2020 | 6 | 0.040 |
Why?
|
| Time Factors | 2 | 2013 | 507 | 0.040 |
Why?
|
| Proteomics | 1 | 2020 | 15 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 59 | 0.040 |
Why?
|
| Electron Transport Complex IV | 2 | 2013 | 3 | 0.040 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2000 | 1 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2000 | 2 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2000 | 3 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2000 | 2 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 370 | 0.040 |
Why?
|
| Enterococcus faecium | 1 | 2019 | 3 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 3 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2021 | 889 | 0.040 |
Why?
|
| Actinomycetales | 1 | 2018 | 2 | 0.040 |
Why?
|
| Trehalose | 1 | 2018 | 2 | 0.040 |
Why?
|
| Naphthalimides | 1 | 2018 | 2 | 0.040 |
Why?
|
| Molecular Probes | 1 | 2018 | 4 | 0.040 |
Why?
|
| Health Priorities | 1 | 2019 | 62 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 11 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2021 | 1160 | 0.040 |
Why?
|
| United States | 1 | 2017 | 132 | 0.040 |
Why?
|
| Research | 1 | 2017 | 65 | 0.030 |
Why?
|
| Asparagine | 1 | 2016 | 1 | 0.030 |
Why?
|
| Glutamine | 1 | 2016 | 1 | 0.030 |
Why?
|
| Codon | 1 | 2016 | 7 | 0.030 |
Why?
|
| Antibiotics, Antitubercular | 1 | 2017 | 47 | 0.030 |
Why?
|
| Phosphines | 1 | 2016 | 1 | 0.030 |
Why?
|
| Palladium | 1 | 2016 | 2 | 0.030 |
Why?
|
| Platinum | 1 | 2016 | 5 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 32 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 188 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 84 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 125 | 0.030 |
Why?
|
| Cell Line | 1 | 2016 | 93 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 139 | 0.030 |
Why?
|
| Guanine | 1 | 2015 | 3 | 0.030 |
Why?
|
| Hydroxyl Radical | 1 | 2015 | 3 | 0.030 |
Why?
|
| Mutagens | 1 | 2015 | 5 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2015 | 19 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2015 | 32 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 11 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2017 | 656 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2017 | 472 | 0.030 |
Why?
|
| Mutation Rate | 1 | 2013 | 7 | 0.030 |
Why?
|
| Heme | 1 | 2013 | 1 | 0.030 |
Why?
|
| Thioredoxins | 1 | 2013 | 3 | 0.030 |
Why?
|
| Temperature | 1 | 2013 | 56 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 217 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 18 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 179 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 6 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2010 | 1 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2010 | 5 | 0.020 |
Why?
|
| DNA Damage | 1 | 2010 | 12 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 2008 | 2 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2008 | 13 | 0.020 |
Why?
|
| Base Sequence | 1 | 2008 | 149 | 0.020 |
Why?
|
| Citrate (si)-Synthase | 1 | 2008 | 1 | 0.020 |
Why?
|
| Methylmalonyl-CoA Mutase | 1 | 2008 | 1 | 0.020 |
Why?
|
| Acyl Coenzyme A | 1 | 2008 | 2 | 0.020 |
Why?
|
| Rabbits | 1 | 2008 | 35 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 60 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2007 | 1 | 0.020 |
Why?
|
| Guanidines | 1 | 2007 | 8 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2007 | 16 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 22 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 44 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2007 | 107 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 142 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2005 | 4 | 0.020 |
Why?
|
| Aerobiosis | 1 | 2005 | 1 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2005 | 1 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2005 | 6 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2000 | 4 | 0.010 |
Why?
|
| Histidine | 1 | 2000 | 9 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 27 | 0.010 |
Why?
|
| Binding Sites | 1 | 2000 | 43 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 35 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 34 | 0.010 |
Why?
|